Amyloid imaging and cognitive decline in nondemented oldest-old: the 90+ Study

Alzheimers Dement. 2013 Mar;9(2):199-203. doi: 10.1016/j.jalz.2012.06.005. Epub 2012 Nov 16.

Abstract

Background: The goal of this study was to examine cross-sectional and longitudinal associations between cognitive performance and beta amyloid (Aβ) load determined by florbetapir F18 positron emission tomography (PET) in nondemented oldest-old.

Methods: Thirteen nondemented (normal or cognitively impaired nondemented) participants (median age, 94.2 years) from The 90+ Study underwent florbetapir-PET scanning within 3 months of baseline neuropsychological testing. Amyloid load was measured with a semi-automated quantitative analysis of average cortical-to-cerebellar standardized uptake value ratio (SUVr) and a visual interpretation (Aβ- or Aβ+). Neuropsychological testing was repeated every 6 months.

Results: At baseline, SUVr correlated significantly with tests of global cognition and memory. During follow-up (median, 1.5 years), the Aβ+ group had steeper declines on most cognitive tests, particularly global cognitive measures.

Conclusion: This preliminary study suggests that greater amyloid load is associated with poorer cognition and faster cognitive decline in nondemented oldest-old. Amyloid load may identify individuals at increased risk of developing Alzheimer's disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Amyloid / analysis*
  • Amyloid / metabolism
  • Brain / diagnostic imaging*
  • Brain / metabolism
  • Cognition Disorders / diagnostic imaging*
  • Cognition Disorders / metabolism
  • Cross-Sectional Studies
  • Female
  • Humans
  • Male
  • Neuropsychological Tests
  • Positron-Emission Tomography

Substances

  • Amyloid